Chemical and pharmacological significance of 1,4-dihydropyridines

Current Organic Chemistry

Volumn 11, Issue 10, 2007, Pages 847-852

  Reddy, Ghanta Mahesh ^a   Shiradkar, Mehendra ^a   Chakravarthy, Akula Kalyan ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

4 unsubstituted pyridine; Calcium antagonists; Electron withdrawing groups; Hypertension; Vasodilation

Indexed keywords

CALCIUM;

4-UNSUBSTITUTED PYRIDINE; CALCIUM ANTAGONIST; CALCIUM CHANNELS; CHANNEL BLOCKING; DIHYDROPYRIDINES; ELECTRON WITHDRAWING GROUP; HYPERTENSION; VASODILATION;

PYRIDINE;

1 BENZYL 3 PYRROLIDINYLMETHYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; 1,4 DIHYDRO 2,6 DIMETHYL 4 PYRIDINYLPYRIDINE 3,5 DICARBOXYLATE DERIVATIVE; 1,4 DIHYDROPYRIDINE DERIVATIVE; 1,4 DIPHENYLDIHYDROPYRIDINE; 2 [2 (2 AMINOETHYL)ETHOXYMETHYL] 4 (2,3 DICHLOROPHENYL) 6 METHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; 4 (DIHYDROPYRIDINYL) 1,4 DIHYDRO 2,6 DIMETHYL 3,5 PYRIDINE DICARBOXYLATE DERIVATIVE; 4 ARYL 1,4 DIHYDROPYRIDINE DERIVATIVE; 4 ARYLHETEROARYL 2,6 DIMETHYL 3,5 BIS N (ARYLCARBAMOYL) 1,4 DIHYDROPYRIDINE DERIVATIVE; 4 ISOXAZOLYL 1,4 DIHYDROPYRIDINE DERIVATIVE; AMLODIPINE; CALCIUM CHANNEL; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE; FLORDIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE; UNCLASSIFIED DRUG;

DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 35348877232     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527207781024058     Document Type: Review

References (44)

1. Schramm, G.; Thomas, M. Nature, 1983, 303, 9.
2. Bernard, L.; Marjorie, M.G.; Kenneth, M.S.; Ralph, T.; Edward, M., J. Med. Chem., 1974, 17, 956.
3. Fleckenstein, A.A. Rev. Pharmac. Tax., 1977, 17, 149.
4. Lyle, R.E.; Anderson, P.S. Rev. Pharmac. Tax., 1966, 6, 45.
5. Wong, W.C.; Chiu, G.; Wetzel, G.; Marzabadi, J. M.; Nagarathnam, M.R.; Wang, D.; Fang, D.; Miao, F.; Hong, S.W.; Forray, X.; Vaysse, C.; Branchek, P.J.-J.; Gluchowski, C.T.A. J. Med. Chem., 1998, 41, 2643.
6. John, D.H.; Schwender, C.F.; Moore, J.B., Ritchie, D.M.; Gray-Nunez, Y.; Loughney, D.; Mockoviak, S. Drug Des. Discov., 1998, 15, 135.
7. Donkar, I.D.; Zhou, X.; Schmidt, J.; Agarwal, K.C.; Kishore, V. Bioorg. Med. Chem., 1998, 6, 563.
8. Hantzsch. Justus Liebigs. Ann. Chem., 1882, 215, 1.
9. Collie, J.N. Justus Liebigs. Ann. Chem., 1884, 256, 294.
10. Eiden, F.; Braatz, K. Greeske D.A.Z., 1983, 123, 2003.
11. Alajarin, R.; Vaquero, J.J.; Garaa, N.J.; Aware- B, J. Syn. Lett., 1992, 297.
12. Zhang, Y.-W.; Shen, Z.-X.; Pan, B.; Lu, X.-H.; Chen, M.-H. Synth. Commun., 1995, 25, 857.
13. Khadilkar, B.; Chitnavis, A. Indian. J. Chem., 1995, 34B, 652.
14. Alajarin, R.; Jordan, P.; Vaquero, J.; Alvarez, B.J. Synthesis, 1995, 389.
15. Swamy, S.K.; Reddy, T.M.; Reddy, V.M. Indian J. Pharm. Sci., 1998, 60(2), 102.
16. Swamy, S.K.; Prabhakar, M.C.; Reddy, V.M. Indian Drugs, 1998, 35(3), 150.
17. Reddy, V.M. AAPS Annual Meeting and Exposition held at Denver, USA during Oct. 21-25, 2001, Abst. No. 1245.
18. Reddy, V.M. Annual Meeting and Exposition held at Denver, USA during Nov. 10-14, 2002, Abst. No. M1178.
19. Tilve, R.D.; Alexander, V.M.; Khadilkar, B.M. Tetrahedron Lett., 1998, 39, 1117.
20. Saurez, M.; Loupy, A.; Perez, E.; Moran, L.; Gerona, G.; Morales, A. Autie. Heterocycl. Commun., 1996, 2, 275.
21. Derakhshandeh; Zarghi, A. British Pharmaceutical Conference, Abstract Book; 233, 2001.
22. Severine, T.; Guy, C.; Didier, B.; Vanden, E.; Jacques, J. Moleculesm, 2002, 7, 528.
23. Fuji, M. Rikogakuhen., 1997, 26, 17.
24. Penieres, G.; Garcia, O.; Franco, K.; Hernandez, O.; Alvarez, C. Heterocycl. Commun., 1996, 2, 359.
25. Ian, C.C.; Alexander, Y.U.; John, M,A.; Douglas, S. C.; Jonathan S.D.; Peter, C.M.; Yuri, L.K. Tetrahedron Lett., 1998, 39, 1117.
26. Bellemann, P.; Ferry, F.; Lubbecke; Glossman, M. Arzneim-Forsch, 1981, 31, 2064.
27. Mahmoudian, M.; Richards, W.G. J. Pharm. Pharmacol., 1986, 38, 272.
28. Valenti, P.; Rampa, A.; Budries, R.; Bisi, A.; Chiarini, A. Bioorg. Med. Chem., 1998, 6, 803.
29. Lehmann, J.; Kahlich, R.; Meyer, C.; Schulte, A.; Stephan, K. Portland Press Proc., 1998, 15, 294.
30. Ramesh, M.; Matowe, Wandikayi, C.; Akula, M.R.; Vo, D.; Dagnino, L.; Li-Kwong, K.; Moy C.; Wolowyk, M.W.; Knaus E.E. J. Med. Chem., 1998, 41, 509.
31. Sunkel, C.; Fau de, C.-J.; Miguel, S.; Luis A.S.; Garcia, A.; Prego J. US 5691361, 1997.
32. Nicholas, R.N.; Mark, E.R.; Richard, S.; David, J.T.; Aleta, R. J. Med. Chem., 1999, 42, 3087.
33. Iqbal, N.; Triggle, C.; Knaus, E. Drug Des. Res., 1997, 42, 120.
34. Ger. Patent Office, 2228377 (CL.C07.D) 03, Jan; 1974; Appli. P22, 283778 10 Jan 1972 44pp. Ger. Patent Office. 2524277 (CL CO7.D) 18 Dec. 1975.; Jan. Kkai 75140463 (CL, CO7.DA61K) 11Nov 1995; Jan. Kokai 76133272 (CL. CO&.D211/90) 18Jan. 1978; Chem Abst. 75, 47266e (1971); Chem. Abst. 75, 98407j (1971).
35. Zidermane, A.; Dubens, G.; Zilbeers, A.; Verpele, R.; Latv, PSR, Zinaat, Akad, Vestis, 1971, 4, 77.; Chem. Abst. 216319h, 1978.
36. Palecek, J.; Pavlik, M.; Kuthan, J. Collect. Ezech. Chem. Commun., 1983, 48, 608.; Chem. Abst. 9821545k, 1983.
37. Kazuharu, T.; Hideki, A.; Toshio, F.; Toichi, T.; Osamu, I.; Michio, T. J. Med. Chem., 1986, 29, 2504.
38. Dagnino, L.; Li-Kwong-Ken, M.C.; Wolowyk, M.W.; Wynn, H.; Triggle, C.R.; Knaus, E.E. J. Med. Chem., 1986, 29, 2524.
39. Dagnino, L.; Li-Kwong-Ken, M.C., Wolowyk, M.W.; Wynn, H.; Triggle, C.R.; Knaus, E.E. J. Med. Chem., 1987, 30, 640.
40. Vater, W.; Kronebers, G.; Haffmeister, F.; Kaller, H.; Meng, K.; Obedorff, A.; Puls, W.; Schlossmann, K.; Stopel, K. Arzneim-Forsch, 1972, 22, 330.
41. Meyer, H.; Bossert, F.; Whinger, E.; Stoepel, K.; Vater, W. Arzneim-Forsch, 1981, 31, 407.
42. Iwanami, M.; Shibanume, I.; Fujimoto, M.; Kawai, K.; Tanrazawe, K.; Takenaka, T.; Takanaski, K.; Murakaami, M. Chem. Pharm. Bull., 1979, 27, 407.
43. Towart, R.; Kazda, S, Brit. J. Pharmacol., 1979, 69, 409.
44. Berntsson, P.B. Swed. USPat., 442,298 (1985); Chem. Abst. 4878x, 106, 1987.